IL-6 is another cytokine expressed in tumor cells, and its dysregulation has been implicated in many diseases including malignant tumors for which it has been associated with tumor progression, drug resistance, and poor prognoses [30–36]. The gene discussed is IL6; the disease is neoplasm.